Toba Ophthalmic Solution
₹125
₹125
Toba
Toba Ophthalmic Solution
Net Qty: 5 mL
MRP₹125(incl. of all taxes)
Prescription required
Coupons & Offers
No Return or Exchange
Fast Delivery
Highlights
composition with strength
Tobramycin (0.3% w/v)
key benefits
Treatment of Bacterial eye infections
side effects
Burning sensation , Eye redness and Eye itching
how to use
For external use only. Use it as prescribed by your doctor. Check the label for directions, and gently squeeze the dropper to place the medicine inside the lower eyelid without touching the eye.
pregnancy interaction
Consult Your Doctor
lactation interaction
Safe If Prescribed
driving interaction
Safe
Information
disclaimer
The contents and images displayed on this Platform are for informational purposes only and are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a registered medical practitioner with any questions you may have regarding a medical condition or the use of any product. Do not disregard professional medical advice or delay seeking it because of something you have read on this Platform.We intend to support, not replace, the doctor-patient relationship. While we make every effort to ensure the information provided is accurate and up-to-date, we strongly recommend reviewing product labels, batch numbers, manufacturing and packaging details, as well as any warnings and usage instructions before using or consuming any product.
customer care details
In case of any issue, contact us E-mail address: support@zeptonow.com
Seller Name
Geddit Convenience Private Limited
Seller Address
Geddit Convenience Private Limited, Unit 803, Lodha Supremus, Saki Vihar Road, Opp MTNL, Office, Powai, Mumbai, Maharashtra, India,400072 For Support ReachOut : support+geddit@zeptonow.com
Seller License No.
11521998000248
Manufacturer Name
Sun Pharmaceutical Industries Limited
Manufacturer Address
90, Delhi - Jaipur Road, Sector 32, Gurugram, Haryana 122001
Country of Origin
India
Shelf Life
24 months
Expires on or after
February 2026